Wonder

Research Outline

Prepared for Amanda D. | Delivered March 26, 2020

Connecticut Bioscience Companies and Projects

Goals

To provide specific examples of active projects or research being done in Connecticut.

Early Findings

There are a number of Bioscience projects and companies active in Connecticut. Some are startups and projects being developed into companies, while others are larger, more established life sciences and healthcare companies.

The Accelerator for Biosciences in Connecticut (ABCT) is a "competitive entry, 6-month long program designed for entrepreneurial research students and faculty, MBA's and MD's interested to form new ventures in biosciences." The program has been running for several years now and has turned out some interesting projects and companies. These projects include:
 KovaDx: They are building an image analysis platform for the diagnosis of blood diseases based on deep learning technology.
RBK Biotech: Their product doesn't seem to be built out much, but they're focused on nutrition for cancer care.
 Lactation Innovations: They are "dedicated to developing technologies that help mothers breastfeed with confidence". Their first product for this mission is the Manoula Device, which monitors how much breastmilk a baby has consumed and communicates the data wirelessly with the mother and healthcare providers.
 OnTrack Rehabilitation: Accelerated concussion recovery, safely and efficiently, driven by measurements of the patient's balance as well as ocular and vestibular improvement, all managed through a cloud-based analytic platform.
 QCDx: A "medical device company that designs, manufactures, and sells instruments, consumables and reagents for the detection of rare cells in the blood circulation" that improves early detection of tumor cells and drives curing cancer.
 Vanessa Research: They are "driven by the desire to save children’s lives, develop the first treatment for MVID, and to give patients the chance to live a healthy life".
 Enrich Therapeutics: They develop "novel single cell isolation technology to enhance global life science research at true single cell level".
 Skeletal Phenotyping IMPC/KOMP Mice 
 EliV5: They are developing new anti-fungal drugs to disrupt the pathways of fungal survival.
 DeMay Bio: Their goal is to "develop a new treatment for Rheumatoid Arthritis that leverages the body’s own natural defense mechanisms to block disease signs in the joints that cause pain and mobility loss for patients". 
More established organizations doing research, large and small:
 RallyBio: They are a "privately-held, development-stage biotechnology company focused on bringing life-transforming medicines to patients with devastating and rare disorders".
 BioPharmaWorks: They deliver a "soup-to-nuts approach to drug development through an extensive CRO network, highly specialized expertise, and solutions-based model".

Additional Resources:
 Connecticut Biotech, Pharmaceutical & Life Sciences Companies 
 BioCT connects Connecticut's bioscience industry and is "dedicated to growing the vibrant bioscience ecosystem in Connecticut by supporting innovation, collaboration, networking, education, talent engagement and advocacy."